Navigation Links
Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
Date:6/28/2010

INDIANAPOLIS, June 28 /PRNewswire-FirstCall/ -- Marcadia Biotech, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the companies have signed a development and exclusive license agreement for Marcadia's short-acting glucagon program, covering glucagon analogs that may provide greater convenience and ease-of-use than the current recombinant glucagon for the treatment of severe hypoglycemia. The program includes MAR531, a glucagon analog that is in preclinical development at Marcadia, as well as related backup compounds.

Under the terms of the agreement, Marcadia will continue to oversee development of the compound through regulatory approval in the U.S., while Lilly will be responsible for obtaining regulatory approval in countries outside the U.S. and for commercialization worldwide.  Financial terms of the collaboration were not disclosed.

"Glucagon is an important therapeutic for people with diabetes to treat an episode of severe hypoglycemia, but the currently marketed products require  reconstitution from a lyophilized (powder) form before administering an injection," said Enrique Conterno, president of Lilly Diabetes. "A new glucagon therapy that can be stored in solution form at room temperature and supplied in a convenient injection device could be an important advance for patients."

Fritz French, chief executive officer of Marcadia, added, "Lilly's long experience and expertis
'/>"/>

SOURCE Eli Lilly and Company; Marcadia Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes
2. Lilly Declares Third-Quarter 2010 Dividend
3. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
4. Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
5. Lilly to Acquire Global License to AXIRON Testosterone Solution From Acrux
6. Lillys Online, Interactive Health Education Program Receives Two Web Awards
7. Lilly Reports Fourth-Quarter and Full-Year 2009 Results
8. Lilly Confirms Date and Conference Call For Fourth-Quarter and Full-Year 2009 Financial Results Announcement
9. Lilly CEO Stresses Human Element in Driving Medical Innovation
10. Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
11. PDL BioPharma Announces New Licensing Agreement With Eli Lilly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Arbor Pharmaceuticals, LLC. - ... Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product ... the Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Arbor Pharmaceuticals, ... therapeutics assessment by drug target, mechanism of action ...
(Date:9/30/2014)... 2014 According to ... by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments ... Application (Immunology, Oncology) & by End User ... MarketsandMarkets, provides a detailed overview of the ... trends, and strategies impacting the global glycomics ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
(Date:9/30/2014)... Calif., Sept. 30, 2014 Research by UC Irvine ... functions, shedding light on a vital process that determines ... In the online version of Nature Immunology , ... and other Institute for Immunology colleagues describe a critical ... released into the bloodstream. , A T cell is ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 EverStryke , ... free introduction to SurvivalLife.com along with a free book and ... attention of Shane Michaels, prompting an investigative review. , ... people in the survival and preparation niche, and this product ... the great classes and survival products that Joe offers on ...
(Date:9/30/2014)... Los Angeles, CA (PRWEB) September 30, 2014 ... plastic surgery providers in Turkey has gone up more ... of growth. The medical tourism company also reported total ... since October 2012. , The company’s professional strategy has ... in Turkey — ultimately designed for patient comfort and ...
(Date:9/30/2014)... 2014 Regenerative Medicine Solutions (RMS) is ... in Nashville, Tennessee. RMS welcomes the launch of an ... expansion of a new treatment center for the Lung ... Apnea Institute to Nashville, the hope is to bring ... both diagnosed and undiagnosed. With Nashville being a hub ...
(Date:9/30/2014)... Bifidobacteria, the primary bacteria found in the ... stress, so a high Bifido probiotic can help replenish ... Flora™ Men’s Complete contains 90 Billion live probiotic ... to support a healthy large intestine (colon) where elimination ... billion cultures from 7 Lactobacillus strains to help maintain ...
Breaking Medicine News(10 mins):Health News:UCI study uncovers important process for immune system development 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Regenerative Medicine Solutions Expanding 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2
... year,s Pennsylvania Farm Show can take advantage of free flu ... of Health,s "Body Shop" exhibit."Pennsylvania,s flu season got off to ... on the rise. Getting a flu shot now is the ... of illness," said acting Secretary of Health Everette James. Designed ...
... Keep Commitments the Whole Year ThroughWILSONVILLE, Ore., Jan. 8 ... . play video games? Just days ago, millions of Americans ... healthier and more productive lives. Whether it was a commitment ... ally can be found in the hottest video games of ...
... Japanese testing reveals longer protection from nausea and vomiting ... that better prevents the nausea and vomiting that commonly ... horizon, Japanese researchers report. , Studies headed by a ... palonosetron was not only as effective as the common ...
... America, Inc. launches its,next generation P-55C dye-sublimation thermal disc ... the CES Show at,the Las Vegas Convention Center, January ... printer can be integrated with 3 TEAC Autoprinter,configurations, TEAC ... and AL550S, customers can print up to 68 discs ...
... LAS VEGAS, Jan. 8 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... United States opened for patient enrollment for,its ACORD Phase ... heart,disease. The sites are University of California ... Lauderdale, FL. , Mercy Hospital ...
... MDS Inc. (TSX: MDS; NYSE: MDZ ), a ... sciences markets, today reported its final fourth-quarter results following the ... 31, 2008. , As previously announced, for the fourth quarter ... value of the MDS Pharma Services goodwill write-down, previously estimated ...
Cached Medicine News:Health News:Video Games Make New Year's Resolutions Easier to Keep 2Health News:Video Games Make New Year's Resolutions Easier to Keep 3Health News:TEAC America Launches its Next Generation P-55C Printer, World's Fastest Dye-Sublimation Disc Printer 2Health News:CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial 2Health News:MDS Reports Final Fourth-Quarter 2008 Results 2Health News:MDS Reports Final Fourth-Quarter 2008 Results 3Health News:MDS Reports Final Fourth-Quarter 2008 Results 4
... with 96-well plates in mind, Pipetman ... molecular biology applications: PCR* sequencing, immunology ... etc. Used with Diamond Tips from ... product will maximize performance and assure ...
... Focus multichannel pipettes speed ... reagents into microplates, with ... l volumes. The improved ... Focus multichannels, combined with ...
... series in colonies, rows, and microplatesthat is ... multichannel pipette is becoming an ever-increasing force. ... was the main reason that the Multichannel ... or 12-channel pipette provides effective, precise, and ...
... Finnpipette Focus multichannel ... dispensing of reagents into ... for 0.1-10 l volumes. ... of Finnpipette Focus multichannels, ...
Medicine Products: